“Optimal retreatment strategies for patients with chronic hepatitis C virus (HCV) infection who have failed treatment with direct-acting antiviral (DAA) regiments are not yet clearly defined,” said Fred Poordad, MD, PhD.
Newsroom
“Optimal retreatment strategies for patients with chronic hepatitis C virus (HCV) infection who have failed treatment with direct-acting antiviral (DAA) regiments are not yet clearly defined,” said Fred Poordad, MD, PhD.